AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2017
Sep 11, 2017
30786_dirs_2017-09-11_31d61eb7-1b75-43b0-8816-9c23b739c4e9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2017-09-07
Reporting Person: HUTTON RONALD W (Vice President and Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-07 | Bio-Rad A Common Stock | M | 170 | — | Acquired | 3147.191 | Direct |
| 2017-09-07 | Bio-Rad A Common Stock | F | 64 | $215.44 | Disposed | 3083.191 | Direct |
| 2017-09-10 | Bio-Rad A Common Stock | M | 150 | — | Acquired | 3233.191 | Direct |
| 2017-09-10 | Bio-Rad A Common Stock | F | 57 | $218.42 | Disposed | 3176.191 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-09-07 | Restricted Stock Units | $0 | M | 170 | Disposed | Bio-Rad A Common Stock (170) | Direct | |
| 2017-09-10 | Restricted Stock Units | $0 | M | 150 | Disposed | Bio-Rad A Common Stock (150) | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3: The restricted stock units vest in five equal annual installments beginning September 7, 2017.
F4: The restricted stock units vest in five equal annual installments beginning September 10, 2015.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13